Docusign (NASDAQ:DOCU) Insider Sells $683,945.02 in Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 15,902 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $43.01, for a total transaction of $683,945.02. Following the transaction, the insider owned 72,805 shares of the company’s stock, valued at approximately $3,131,343.05. This represents a 17.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Performance

Shares of NASDAQ DOCU opened at $44.24 on Thursday. The company has a market cap of $8.45 billion, a P/E ratio of 28.73, a P/E/G ratio of 1.29 and a beta of 0.92. The firm’s fifty day moving average is $47.08 and its two-hundred day moving average is $51.93. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $86.65.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. The business had revenue of $830.24 million during the quarter, compared to the consensus estimate of $824.71 million. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.90 EPS. As a group, analysts forecast that Docusign Inc. will post 1.97 EPS for the current fiscal year.

Docusign announced that its board has approved a share repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 21% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign expanded its AI strategy by integrating IAM with Perplexity, a move that could strengthen adoption and deepen its role in automated agreement management. Docusign & Perplexity Help Legal Teams Automate Enterprise-wide Contract Workflows
• Positive Sentiment: The new integration may support Docusign’s growth narrative by reducing manual contract work for in-house legal teams and improving workflow automation across sales, procurement, and HR. Docusign & Perplexity Help Legal Teams Automate Enterprise-wide Contract Workflows
• Positive Sentiment: Investors also appear to be encouraged by Docusign’s continued focus on subscription revenue, eSignature demand, and partnership-driven expansion, which support the company’s long-term platform story. Subscription Revenues & Partnerships Aid Docusign Amid Low Liquidity
• Neutral Sentiment: The stock also remains in focus amid broader software sector rotation and investor attention on AI winners versus laggards, which may be adding to trading activity but is not a direct fundamental driver. DocuSign (DOCU) stock trades up, here is why
• Negative Sentiment: Offsetting the optimism, recent commentary still points to pricing pressure, weak liquidity, and mixed analyst sentiment, while an insider sale may add a small overhang for some investors. Docusign (NASDAQ:DOCU) Insider Sells $683,945.02 in Stock

Institutional Investors Weigh In On Docusign

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Central Pacific Bank Trust Division purchased a new position in shares of Docusign in the 4th quarter worth approximately $25,000. Modus Advisors LLC purchased a new stake in Docusign during the 4th quarter valued at $27,000. Torren Management LLC purchased a new stake in Docusign during the 4th quarter valued at $28,000. Aventura Private Wealth LLC bought a new stake in Docusign in the fourth quarter worth $30,000. Finally, True Wealth Design LLC boosted its stake in Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after buying an additional 222 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Morgan Stanley reduced their price objective on Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 18th. UBS Group set a $60.00 target price on Docusign in a research report on Friday, June 5th. Citizens Jmp cut their target price on shares of Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a report on Wednesday, March 18th. Piper Sandler reduced their price target on shares of Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 18th. Finally, BTIG Research decreased their price target on shares of Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Three investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $60.27.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.